These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14320182)

  • 1. [COMPARATIVE EVALUATION OF BCG SUBSTRAINS IN EXPERIMENTS ON WHITE MICE].
    ROZENBERG AM
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Nov; 41():68-73. PubMed ID: 14320182
    [No Abstract]   [Full Text] [Related]  

  • 2. [COMPARISON OF BCG VACCINES PRODUCED IN POLAND WITH BCG VACCINES PREPARED FROM BCG SUBSTRAINS OF VARIOUS ORIGINS].
    BURACZEWSKA M; KURYLOWICZ W; PAKLERSKA-POBRATYN H
    Gruzlica (1926); 1964 Sep; 32():781-8. PubMed ID: 14249995
    [No Abstract]   [Full Text] [Related]  

  • 3. [COMPARATIVE STUDY OF THE PROTECTIVE POWER OF ORAL BCG IN WHITE AND BROWN MICE].
    LOPES EA; FERREIRA OT
    Hospital (Rio J); 1963 Nov; 64():1075-85. PubMed ID: 14126184
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis.
    Castillo-Rodal AI; Castañón-Arreola M; Hernández-Pando R; Calva JJ; Sada-Díaz E; López-Vidal Y
    Infect Immun; 2006 Mar; 74(3):1718-24. PubMed ID: 16495544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [COMPARATIVE STUDY OF BCG STRAINS FROM PARIS AND BUDAPEST].
    LUGOSI L; LEVY FM
    Acta Microbiol Acad Sci Hung; 1964-1965; 11():391-7. PubMed ID: 14314677
    [No Abstract]   [Full Text] [Related]  

  • 6. THE EFFECTS IN MICE OF INFECTION WITH GROUP IIIA UNCLASSIFIED MYCOBACTERIA AND BCG ON CHALLENGE INFECTION WITH M. TUBERCULOSIS.
    DUNBAR FP; CACCIATORE R; ARMSTRONG AL
    Am Rev Respir Dis; 1964 Feb; 89():280-3. PubMed ID: 14117691
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.
    Oettinger T; Jørgensen M; Ladefoged A; Hasløv K; Andersen P
    Tuber Lung Dis; 1999; 79(4):243-50. PubMed ID: 10692993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [TUBERCULOSIS VACCINATION WITH THE KILLED BCG].
    PHAMNGOC TACH ; D ANGDUC TRACH ; NGUYENTHIH OI
    Poumon Coeur; 1964; 20():923-48. PubMed ID: 14244375
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological characteristics and behaviour in vivo of various substrains of BCG.
    PIERCE CH; DUBOS RJ
    Tubercle; 1955 Apr; 36(4):105-7. PubMed ID: 14373950
    [No Abstract]   [Full Text] [Related]  

  • 11. [ON THE SPECIFICITY IN IMMUNITY TO TUBERCULSOSIS. I. IMMUNIZATION EXPERIMENT WITH UNCLASSIFIED MYCOBACTERIA].
    INUI A
    Nihon Saikingaku Zasshi; 1963 Nov; 18():410-7. PubMed ID: 14110995
    [No Abstract]   [Full Text] [Related]  

  • 12. RELATIONSHIP BETWEEN THE DOSE OF PHENOL-KILLED MYCOBACTERIA AND APPEARANCE OF IMMUNITY.
    TSUKAMURA M; TSUKAMURA S
    Jpn J Tuberc; 1964 Dec; 12():55-7. PubMed ID: 14312617
    [No Abstract]   [Full Text] [Related]  

  • 13. [THE EFFECT OF BCG VACCINE ON ANTI-TETANUS IMMUNITY IN IRRADIATED AND NON-IRRADIATED MICE].
    ZEMSKOV VM
    Med Radiol (Mosk); 1964 Sep; 9():67-72. PubMed ID: 14252334
    [No Abstract]   [Full Text] [Related]  

  • 14. [EFFECT OF LARGE DOSES OF CAFFEINE ON THE FORMATION OF IMMUNITY TO TUBERCULOSIS IN VACCINATED WHITE MICE].
    PERELMAN AE
    Biull Eksp Biol Med; 1964 Sep; 58():102-6. PubMed ID: 14273444
    [No Abstract]   [Full Text] [Related]  

  • 15. [IMPROVED METHOD FOR THE DETERMINATION OF THE VIABILITY OF BCG VACCINE].
    IABLOKOVA TB; PISARENKO NN; RAKHIMOVA NG
    Probl Tuberk; 1964; 42():72-7. PubMed ID: 14195841
    [No Abstract]   [Full Text] [Related]  

  • 16. ACQUIRED RESISTANCE TO TUBERCULOSIS INDUCED IN RED MICE (CLETHRIONOMYS G. GLAREOLUS SCHREB.) BY VACCINATION WITH LIVING BCG. 2. DETERMINATION OF DOSAGE RANGE FOR CHALLENGE.
    JESPERSEN A; BENTZON MW
    Acta Pathol Microbiol Scand; 1963; 59():383-99. PubMed ID: 14064819
    [No Abstract]   [Full Text] [Related]  

  • 17. Crucial requirement for standardization during the development of novel recombinant BCG vaccines: Does the corresponding substrain background matter?
    Antas PR
    Hum Vaccin Immunother; 2016 Dec; 12(12):3099-3102. PubMed ID: 27454883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies of anti-tuberculosis vaccination of guinea pigs with Mycobacterium tuberculosis var. muris and with BCG].
    GROSSO E
    Boll Ist Sieroter Milan; 1955; 34(11-12):712-20. PubMed ID: 13293258
    [No Abstract]   [Full Text] [Related]  

  • 19. IMMUNOGENICITY OF GAMMA-IRRADIATED MYCOBACTERIUM TUBERCULOSIS H37RV (GIV) IN MICE.
    NISHIHARA H; LAWRENCE CA; TAPLIN GV; CARPENTER CM
    Am Rev Respir Dis; 1963 Dec; 88():827-32. PubMed ID: 14087235
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adaptation of BCG in the organism of white mice in parenteral methods of administration].
    ROZENBERG KhM
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Aug; 8():42-6. PubMed ID: 13206342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.